ong-term health effects of high and low carbohydrate diets in obese subjects with the metabolic syndrome
Phase 4
Active, not recruiting
- Conditions
- ObesityDiet and Nutrition - Obesity
- Registration Number
- ACTRN12606000203550
- Lead Sponsor
- national health & medical research council of Australia
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
High waist circumferenceat least one cardiovascular risk factor.
Exclusion Criteria
Have proteinuria, a malignancy, or a history of metabolic disease such as liver, kidney, cardiovascular, respiratory or gastrointestinal disease, diabetes (fasting blood glucose or are pregnantUncontrolled hypertension (resting recumbent BP >160/110 mmHg).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms link high vs. low carbohydrate diets to metabolic syndrome in ACTRN12606000203550?
How do high/low carbohydrate diets compare to standard-of-care therapies for obesity-related metabolic syndrome?
Which biomarkers predict differential outcomes in ACTRN12606000203550's carbohydrate diet interventions?
What adverse events are associated with long-term high/low carbohydrate diets in metabolic syndrome patients?
Are there synergistic effects of combining ACTRN12606000203550 diets with pharmacological agents like metformin?